The pharmaceutical landscape for glucose is shifting, and transdermal GLP-1 delivery systems represent a promising advance. Unlike shots, this approach offers a more convenient way to administer GLP-1 drugs. These patches steadily release the drug through the epidermis offering a consistent amoun